Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

7.60
Delayed Data
As of 3:30pm ET
 -0.02 / -0.26%
Today’s Change
5.02
Today|||52-Week Range
13.30
-9.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues1.8M282.0K388.0K185.0K
 
 
 
 
 
Depreciation And Amortization666.6K1.2M2.3M3.6M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses15.7M48.2M66.5M84.0M
 
 
 
 
 
Research And Development11.0M33.6M51.3M65.7M
 
 
 
 
 
Total Operating Expenses16.4M49.4M68.8M87.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.6M-49.1M-68.4M-87.4M
 
 
 
 
 
Extraordinary Charge-67.6M0.000.00-1.8M
 
 
 
Interest Expense On Debt1.8M12.0K1.8M3.7M
 
 
 
 
 
Other Expenses0.00-42.0K-10.0K11.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-84.0M-48.5M-69.2M-91.8M
 
 
 
 
 
Preferred Dividend-1.4M0.000.000.00
 
 
Net Income-84.0M-48.5M-69.2M-91.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5M26.3M27.0M31.7M
 
 
 
 
 
Shares To Calculate EPS Diluted2.5M26.3M27.0M31.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$34.04-$1.84-$2.57-$2.89
 
 
 
 
 
EPS Diluted-$34.04-$1.84-$2.57-$2.89